Michael Wick
0000-0001-5683-8687
2 papers found
Refreshing results…
Covalent ERα Antagonist H3B-6545 Demonstrates Encouraging Preclinical Activity in Therapy-Resistant Breast Cancer
Neratinib is effective in breast tumors bearing both amplification and mutation of ERBB2 (HER2)
Missing publications? Search for publications with a matching author name.